CHMP Endorses Adult RSV Vaccine, Six Other New Drugs in April Meeting

By PacConAdmin | April 27, 2023

The European Medicines Agency’s (EMA) human medicines committee has signed off on GSK’s Arexvy (recombinant, adjuvanted), the first respiratory syncytial virus (RSV) vaccine for adults age 60 years and older as well as six other new drugs at its latest monthly meeting.
Source: Drug Industry Daily

Posted in Drug Industry Daily